Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/06/014591
CTRI/2018/06/014591
Recruiting
Phase 2

An open exploratory clinical trial to assess the efficacy of homoeopathic medicines in the management of morbidity associated with grade III and grade IV lowerlimb lymphoedema in patients with lymphatic filariasis

Central Council for Research in Homoeopathy0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: - Health Condition 2: null- Grade III and grade IV lowerlimb lymphoedema in lymphatic filariasis

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: null- Grade III and grade IV lowerlimb lymphoedema in lymphatic filariasis
Sponsor
Central Council for Research in Homoeopathy
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • •1\.Subjects in the age group 18 ââ?¬â?? 99 years
  • •2\.Both male and female subjects
  • •3\.Subjects with grade III and grade IV unilateral/bilateral lowerlimb lymphoedema with clinical diagnosis/clinical history of lymphatic filariasis
  • •4\.inclusion of patient with controlled diabetes mellitus and controlled hypertension.
  • •5\.Subjects who have given the written informed consent

Exclusion Criteria

  • •1\.Newly diagnosed cases with ADL attacks with grade I and grade II lymphadenopathy
  • •2\.Subjects having lymphoedema due to non filarial causes like congenital lymphoedema, deep vein thrombosis, malignancies, irradiation, surgery, podoconiosis etc.
  • •3\.History of known life threatening disease/systemic illness (tuberculosis,cancer, AIDS, uncontrolled diabetes, uncontrolled hypertension, cardiovascular disorders etc.)
  • •4\.Subjects taking lifelong medication for any other chronic illness.
  • •5\.Pregnant/lactating women
  • •6\.Subject deemed unfit by Investigator and Consultant

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Clinical study to evaluate the efficacy of thyroherb tablet in the management of primary hypothyroidismHealth Condition 1: E05- Thyrotoxicosis [hyperthyroidism]
CTRI/2024/03/063679Pankajakasthuri Herbals India Pvt Ltd
Completed
Not Applicable
Effects of Ginkgo biloba extract EGb 761® on arteriosclerosis-relevant biomarkers in subjects with early stage metabolic syndromeEarly stage metabolic syndromeNutritional, Metabolic, EndocrineMetabolic syndrome
ISRCTN69953971Dr. Willmar Schwabe GmbH & Co. KG (Germany)30
Active, not recruiting
Phase 2
An exploratory clinical trial to Investigate the efficacy and safety of Meclizine hydrochloride in Achondroplasia patients (pediatrics).
JPRN-jRCT2041230001Matsushita Masaki9
Not yet recruiting
Not Applicable
To measure the efficacy of Niger seeds in volunteers having low haemoglobin level.
CTRI/2021/09/036772PDEAs College of Ayurved and Research Centre
Active, not recruiting
Not Applicable
Clinical Trial to evaluate the efficacy and safety of two drugs for pain relieve for pregnant women whose fetus is breech, to attempt to turn the babyThe objective is to demonstrate the superiority of remifentanil versus nitrous oxide as adjuvant analgesic treatment to increase the chances of success of external cephalic version in the management of breech presentation in women with singleton pregnancy at term. Another objective is to compare their safety, tolerability and acceptability.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
EUCTR2011-003952-37-ESIS FERNÁNDEZ- LLEBREZ DEL REY